Scientific Program

8:30

Registration

9:00

Welcome Remarks
Dr. Basel Altrabulsi, UAE
Dr. Mouza AlSharhan, UAE

Session 1
Moderators:Dr. Mouza AlSharhan, UAE

9:10

Papillary Lesions: From Core Biopsy to Excision and Updates
Prof. Cecily Quinn, UK

9:40

Spindle Cell Lesions of the Breast: Diagnostic Pitfalls
Prof. Emad Rakha, UK

10:10

Core Biopsy Coding and dealing with Challenging Lesions
Prof. Abeer Shaaban, UK

10:40

Coffee Break & Networking

Session 2
Moderators:Dr. Shweta Narang, UAE

10:55

Opening Remarks
Dr. Ali Anees

11:05

Reporting Post-Neoadjuvant Therapy Specimens: Key Parameters and Pitfalls
Dr. Elena Provenzano, UK

11:35

Fibroepithelial Lesions: Practical Approach and grade Assessment
Prof. Emad Rakha, UK

12:05

Update on Biomarker Testing in Breast Carcinoma
Dr. Basel Altrabulsi, UAE

12:35

Industry Symposium - AstraZeneca
HER2 Beyond Positive & Negative : International Consensus on HER2 Low and Ultra-low
Prof. Emad Rakha, UK

12:55

Lunch Break

Session 3
Moderators: Dr. Priti Joshi, UAE
Dr. Yasin Ahmed, UAE

14:00

Advances in Digital Breast Pathology and Artificial Intelligence
Prof. Abeer Shaaban, UK

14:30

Key Revisions in the WHO 6th Edition
Prof. Cecily Quinn, UK

15:00

Industry Symposium - Roche
Defining HER2 Status with Certainty for Shaping Therapy
Dr. Jayesh Deshmukh

15:20

Coffee Break

Session 4
Moderators: Dr. Priti Joshi, UAE
Dr. Yasin Ahmed, UAE

15:40

The Role of Frozen Section in Breast Pathology
Dr. Haytham Dimashkieh, UAE

16:10

Breast Specimen Cut-up: Guideline Recommendations and Sampling Standards
Dr. Elena Provenzano, UK

16:40

Industry Symposium - Visole
Fine Needle Aspiration of Thyroid Nodules: From  Conventional Smears to Liquid-Based Cytology—The 8-Year Cleveland Clinic Abu Dhabi Experience
 Dr. Ayoub Nahal, UAE

Session 5
Moderators: Dr. Priti Joshi, UAE
Dr. Asif Quadri

17:00

Ask the expert session
All speakers

17:30

Closing Remarks
Prof. Emad Rakha, UK

08:00

Registration and Welcome
Dr. Basel Altrabulsi, UAE
Dr. Rupali Arora, UK

08:30

Welcome Remarks
Dr. Basel Altrabulsi, UAE
Dr. Rupali Arora, UK

Session 1
Moderator: Dr. Basel Altrabulsi, UAE
Dr. Alexandru Stan, UAE

08:40

Challenges in The Assessment Of Low Grade Serous Neoplasia
Prof. Koen Van De Vijver, Belgium

09:10

Challenges in Reporting Endometriosis Associated Ovarian Neoplasms
Prof. Glenn Mccluggage, UK

09:40

Molecular and Immunohistochemical Testing in Ovarian Tumours
Dr. Rupali Arora, UK

10:10

Industry Symposium - AstraZeneca
From Pathology to Precision Care: Integrating Biomarkers for Targeted Therapies
Dr. Yasin Ahmed, UAE

10:30

Coffee Break & Networking

Session 2
Moderator: Dr. Basel Altrabulsi, UAE
Dr. Alexandru Stan, UAE

10:45

Practical Updates in Vulval Squamous Neoplasia
Dr. Sarah Bell, UK

11:05

What’s New in Uterine Mesenchymal Tumours?
Prof. Joseph Rabban, USA

11:35

Frozen sections in Gynae pathology – focus on ovarian epithelial tumours
Dr. Asif Quadri, UAE

12:00

Industry Symposium - AbbVie
Pathological Perspectives and Implications of FRa Testing in Ovarian Cancer
Dr. Asif Quadri, UAE

12:20

Lunch

Session 3
Moderator: Dr. Ayoub Nahal, UAE
Dr. Haytham Dimashkieh, UAE

13:20

Challenges in Staging Endometrial Carcinoma
Prof. Koen Van De Vijver, Belgium

13:50

Tips and Tricks in The Molecular Classification Of Endometrial Carcinoma
Dr. Sarah Bell, UK

14:20

Practical Approach to Reporting Early Products Of Conception
Prof. Joseph Rabban, USA

14:50

Coffee Break & Networking

Session 4
Moderator: Dr. Ayoub Nahal, UAE
Dr. Haytham Dimashkieh, UAE

15:05

Practical Update in Ovarian Sex Cord Stromal Tumours
Prof. Glenn Mccluggage, UK

15:35

Practical Updates in Cervical Pathology
Dr. Rupali Arora, UK

16:05

Biomarkers in endometrial carcinoma
Dr. Priti Joshi, UAE

16:30

Ask the Expert Session
All Speakers

17:00

Closing Remarks
Dr. Basel Altrabulsi, UAE
Dr. Rupali Arora, UK